Reuters logo
BRIEF-Biophytis says study confirm Sarconeos' good pharmacokinetic profile in elderly patients
March 1, 2017 / 5:35 PM / 9 months ago

BRIEF-Biophytis says study confirm Sarconeos' good pharmacokinetic profile in elderly patients

March 1 (Reuters) - Biophytis SA:

* Full results of SARA-PK study confirm Sarconeos’ good pharmacokinetic profile in elderly patients

* Results show in particular the favourable pharmacokinetics and pharmacodynamics of Sarconeos

* Analyses confirm the good pharmacokinetic profile in healthy elderly volunteers

* Phase 2b study of sara-interest hopefully to start in mid-2017 Source text: bit.ly/2mFn1ZA Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below